{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:28:57Z","timestamp":1785403737091,"version":"3.56.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T00:00:00Z","timestamp":1639180800000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The nutritional status can potentially affect the efficacy of cancer therapy. The Geriatric Nutritional Risk Index (GNRI), a simple index for evaluating nutritional status calculated from body weight and serum albumin levels, has been reported to be associated with the prognosis of various diseases. However, the relationships between GNRI and the efficacy of platinum-based chemotherapy in patients with non-small-cell lung cancer (NSCLC) are unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The pretreatment levels of GNRI were retrospectively evaluated in 148 chemo-na\u00efve patients with advanced NSCLC who received first-line platinum-based chemotherapy and scored as low or high.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients with a high GNRI had a significantly higher overall response rate (ORR; 44.5% [95% confidence interval {CI}\u2009=\u200935.6%\u201353.9%] vs. 15.8% [95% CI\u2009=\u20097.4%\u201330.4%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002), longer median progression-free survival (PFS; 6.3\u00a0months [95% CI\u2009=\u20095.6\u20137.2\u00a0months] vs. 3.8\u00a0months [95% CI\u2009=\u20092.5\u20134.7\u00a0months],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and longer median overall survival (OS; 22.8\u00a0months [95% CI\u2009=\u200916.7\u201327.2\u00a0months] vs. 8.5\u00a0months [95% CI\u2009=\u20095.4\u201316.0\u00a0months],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) than those with low GNRI. High GNRI was independently predictive of better ORR in multivariate logistic regression analysis and longer PFS and OS in multivariate Cox proportional hazard analyses. In 71 patients who received second-line non-platinum chemotherapy, patients with high GNRI exhibited significantly longer PFS and OS than those with low GNRI (both\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>GNRI was predictive of prolonged survival in patients with NSCLC who received first-line platinum-based chemotherapy and second-line non-platinum chemotherapy. Assessment of the nutritional status may be useful for predicting the efficacy of chemotherapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-021-01782-2","type":"journal-article","created":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T01:02:35Z","timestamp":1639184555000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Association of the Geriatric Nutritional Risk Index with the survival of patients with non-small-cell lung cancer after platinum-based chemotherapy"],"prefix":"10.1186","volume":"21","author":[{"given":"Masato","family":"Karayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironao","family":"Hozumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Furuhashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Inui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Suda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,11]]},"reference":[{"key":"1782_CR1","first-page":"1","volume":"12","author":"S Galm\u00e9s","year":"2020","unstructured":"Galm\u00e9s S, Serra F, Palou A. Current state of evidence: Influence of nutritional and nutrigenetic factors on immunity in the COVID-19 pandemic framework. Nutrients. 2020;12:1\u201333.","journal-title":"Nutrients"},{"key":"1782_CR2","doi-asserted-by":"publisher","first-page":"00574","DOI":"10.1183\/23120541.00574-2020","volume":"7","author":"P Faverio","year":"2021","unstructured":"Faverio P, De Giacomi F, Bodini BD, Stainer A, Fumagalli A, Bini F, et al. Nontuberculous mycobacterial pulmonary disease: an integrated approach beyond antibiotics. ERJ Open Res. 2021;7:00574\u20132020. https:\/\/doi.org\/10.1183\/23120541.00574-2020.","journal-title":"ERJ Open Res"},{"key":"1782_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12931-021-01722-y","volume":"22","author":"C Healy","year":"2021","unstructured":"Healy C, Munoz-Wolf N, Strydom J, Faherty L, Williams NC, Kenny S, et al. Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease. Respir Res. 2021;22:1\u201344. https:\/\/doi.org\/10.1186\/s12931-021-01722-y.","journal-title":"Respir Res"},{"key":"1782_CR4","first-page":"1","volume":"14","author":"C Baldessari","year":"2021","unstructured":"Baldessari C, Guaitoli G, Valoriani F, Bonacini R, Marcheselli R, Reverberi L, et al. Impact of body composition, nutritional and inflammatory status on outcome of non-small cell lung cancer patients treated with immunotherapy. Clin Nutr ESPEN. 2021;14:1\u20132.","journal-title":"Clin Nutr ESPEN"},{"key":"1782_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00281-020-00798-w","volume":"42","author":"R Ramalho","year":"2020","unstructured":"Ramalho R, Rao M, Zhang C, Agrati C, Ippolito G, Wang FS, et al. Immunometabolism: new insights and lessons from antigen-directed cellular immune responses. Semin Immunopathol. 2020;42:279\u2013313.","journal-title":"Semin Immunopathol"},{"key":"1782_CR6","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","volume":"83","author":"KC Fearon","year":"2006","unstructured":"Fearon KC, Voss AC, Hustead DS. Definition of cancer cachexia: Effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr. 2006;83:1345\u201350.","journal-title":"Am J Clin Nutr"},{"key":"1782_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjgast-2016-000097","volume":"3","author":"G Vanhoutte","year":"2016","unstructured":"Vanhoutte G, Van De Wiel M, Wouters K, Sels M, Bartolomeeussen L, De Keersmaecker S, et al. Cachexia in cancer: what is in the definition? BMJ Open Gastroenterol. 2016;3:1\u201311.","journal-title":"BMJ Open Gastroenterol"},{"key":"1782_CR8","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","volume":"15","author":"CMM Prado","year":"2009","unstructured":"Prado CMM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, Tonkin K, et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res. 2009;15:2920\u20136.","journal-title":"Clin Cancer Res"},{"key":"1782_CR9","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1038\/sj.bjc.6601781","volume":"90","author":"PJ Ross","year":"2004","unstructured":"Ross PJ, Ashley S, Norton A, Priest K, Waters JS, Eisen T, et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer. 2004;90:1905\u201311.","journal-title":"Br J Cancer"},{"key":"1782_CR10","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","volume":"17","author":"JS Temel","year":"2016","unstructured":"Temel JS, Abernethy AP, Currow DC, Friend J, Duus EM, Yan Y, et al. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol. 2016;17:519\u201331. https:\/\/doi.org\/10.1016\/S1470-2045(15)00558-6.","journal-title":"Lancet Oncol"},{"key":"1782_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41591-018-0221-5","volume":"25","author":"Z Wang","year":"2019","unstructured":"Wang Z, Aguilar EG, Luna JI, Dunai C, Khuat LT, Le CT, et al. Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. Nat Med. 2019;25:141\u201351.","journal-title":"Nat Med"},{"key":"1782_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1039\/C0MT00058B","volume":"3","author":"M Sooriyaarachchi","year":"2011","unstructured":"Sooriyaarachchi M, Narendran A, Gailer J. Comparative hydrolysis and plasma protein binding of cis-platin and carboplatin in human plasma in vitro. Metallomics. 2011;3:49\u201355.","journal-title":"Metallomics"},{"key":"1782_CR13","doi-asserted-by":"publisher","first-page":"7932","DOI":"10.3390\/ijms21217932","volume":"21","author":"CR Park","year":"2020","unstructured":"Park CR, Kim HY, Song MG, Lee Y. Efficacy and safety of human serum albumin\u2014cisplatin complex in U87MG xenograft mouse models. Int J Mol Sci. 2020;21:7932.","journal-title":"Int J Mol Sci"},{"key":"1782_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejps.2021.105723","volume":"159","author":"Y Liang","year":"2021","unstructured":"Liang Y, Xu L, Yang H, Xu W, Hu R, Fan X, et al. Analysis on the interaction and binding properties of daphnoretin and human serum albumin in the presence of cisplatin: multi-spectroscopic methods and docking simulation. Eur J Pharm Sci. 2021;159:1\u20132.","journal-title":"Eur J Pharm Sci"},{"key":"1782_CR15","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/ajcn\/82.4.777","volume":"82","author":"O Bouillanne","year":"2005","unstructured":"Bouillanne O, Morineau G, Dupant C, Coulombel I, Vincent JP, Nicolis I, et al. Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr. 2005;82:777\u201383.","journal-title":"Am J Clin Nutr"},{"key":"1782_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.clnu.2018.01.019","volume":"38","author":"Y Matsukuma","year":"2019","unstructured":"Matsukuma Y, Tanaka S, Taniguchi M, Nakano T, Masutani K, Hirakata H, et al. Association of geriatric nutritional risk index with infection-related mortality in patients undergoing hemodialysis: the Q-Cohort Study. Clin Nutr. 2019;38:279\u201387.","journal-title":"Clin Nutr"},{"key":"1782_CR17","doi-asserted-by":"publisher","first-page":"e22217","DOI":"10.1097\/MD.0000000000022217","volume":"99","author":"L Wei","year":"2020","unstructured":"Wei L, Xie H, Li J, Li R, Chen W, Huang L, et al. The prognostic value of geriatric nutritional risk index in elderly patients with severe community-acquired pneumonia: a retrospective study. Medicine (Baltimore). 2020;99:e22217.","journal-title":"Medicine (Baltimore)"},{"key":"1782_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.6061\/clinics\/2021\/e2258","volume":"76","author":"CH Dong","year":"2021","unstructured":"Dong CH, Chen SY, Zeng HL, Yang B, Pan J. Geriatric nutritional risk index predicts all-cause mortality in patients with heart failure: a systematic review and meta-analysis. Clinics. 2021;76:1\u20137.","journal-title":"Clinics"},{"key":"1782_CR19","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.hrtlng.2015.08.004","volume":"44","author":"T Matsumura","year":"2015","unstructured":"Matsumura T, Mitani Y, Oki Y, Fujimoto Y, Ohira M, Kaneko H, et al. Comparison of Geriatric Nutritional Risk Index scores on physical performance among elderly patients with chronic obstructive pulmonary disease. Hear Lung J Acute Crit Care. 2015;44:534\u20138.","journal-title":"Hear Lung J Acute Crit Care"},{"key":"1782_CR20","doi-asserted-by":"publisher","first-page":"9038","DOI":"10.1038\/s41598-021-88254-z","volume":"11","author":"H Kanno","year":"2021","unstructured":"Kanno H, Goto Y, Sasaki S, Fukutomi S, Hisaka T, Fujita F, et al. Geriatric nutritional risk index predicts prognosis in hepatocellular carcinoma after hepatectomy: a propensity score matching analysis. Sci Rep. 2021;11:9038. https:\/\/doi.org\/10.1038\/s41598-021-88254-z.","journal-title":"Sci Rep"},{"key":"1782_CR21","doi-asserted-by":"publisher","first-page":"532","DOI":"10.21037\/atm-20-6493","volume":"9","author":"Q-N Tang","year":"2021","unstructured":"Tang Q-N, Qiu H-Z, Sun X-Q, Guo S-S, Liu L-T, Wen Y-F, et al. Geriatric nutritional risk index as an independent prognostic factor in locally advanced nasopharyngeal carcinoma treated using radical concurrent chemoradiotherapy: a retrospective cohort study. Ann Transl Med. 2021;9:532\u2013532.","journal-title":"Ann Transl Med"},{"key":"1782_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2020.601513","volume":"11","author":"LW Chang","year":"2021","unstructured":"Chang LW, Hung SC, Li JR, Chiu KY, Yang CK, Chen CS, et al. Geriatric Nutritional Risk Index as a prognostic marker for patients with metastatic castration-resistant prostate cancer receiving docetaxel. Front Pharmacol. 2021;11:1\u20138.","journal-title":"Front Pharmacol"},{"key":"1782_CR23","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.suronc.2017.09.006","volume":"26","author":"F Shoji","year":"2017","unstructured":"Shoji F, Matsubara T, Kozuma Y, Haratake N, Akamine T, Takamori S, et al. Preoperative Geriatric Nutritional Risk Index: a predictive and prognostic factor in patients with pathological stage I non-small cell lung cancer. Surg Oncol. 2017;26:483\u20138.","journal-title":"Surg Oncol"},{"key":"1782_CR24","doi-asserted-by":"crossref","unstructured":"Peng SM, Yu N, Ren JJ, Xu JY, Chen GC, Yang JR, et al. The geriatric nutritional risk index as a prognostic factor in patients with advanced non-small-cell lung cancer. Nutr Cancer. 2020; :33356605.","DOI":"10.1080\/01635581.2020.1865423"},{"key":"1782_CR25","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1111\/1759-7714.13909","volume":"12","author":"K Sonehara","year":"2021","unstructured":"Sonehara K, Tateishi K, Araki T, Komatsu M, Yamamoto H, Hanaoka M. Prognostic value of the geriatric nutritional risk index among patients with previously treated advanced non-small cell lung cancer who subsequently underwent immunotherapy. Thorac Cancer. 2021;12:1366\u201372.","journal-title":"Thorac Cancer"},{"key":"1782_CR26","doi-asserted-by":"publisher","first-page":"4496","DOI":"10.3390\/ijms22094496","volume":"22","author":"CJ Wiedermann","year":"2021","unstructured":"Wiedermann CJ. Hypoalbuminemia as surrogate and culprit of infections. Int J Mol Sci. 2021;22:4496.","journal-title":"Int J Mol Sci"},{"key":"1782_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/17512433.2018.1412827","volume":"11","author":"R Ferrer","year":"2018","unstructured":"Ferrer R, Mateu X, Maseda E, Y\u00e9benes JC, Aldecoa C, De Haro C, et al. Non-oncotic properties of albumin. A multidisciplinary vision about the implications for critically ill patients. Expert Rev Clin Pharmacol. 2018;11:125\u201337.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"1782_CR28","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1038\/onc.2016.406","volume":"36","author":"L Erpenbeck","year":"2017","unstructured":"Erpenbeck L, Sch\u00f6n MP. Neutrophil extracellular traps: Protagonists of cancer progression? Oncogene. 2017;36:2483\u201390.","journal-title":"Oncogene"},{"key":"1782_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fimmu.2019.00012","volume":"10","author":"E Neubert","year":"2019","unstructured":"Neubert E, Senger-Sander SN, Manzke VS, Busse J, Polo E, Scheidmann SEF, et al. Serum and serum albumin inhibit in vitro formation of Neutrophil Extracellular Traps (NETs). Front Immunol. 2019;10:12.","journal-title":"Front Immunol"},{"key":"1782_CR30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"1782_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12123802","volume":"12","author":"RC Augustin","year":"2020","unstructured":"Augustin RC, Delgoffe GM, Najjar YG. Characteristics of the tumor microenvironment that influence immune cell functions: Hypoxia, oxidative stress, metabolic alterations. Cancers (Basel). 2020;12:1\u201317.","journal-title":"Cancers (Basel)"},{"key":"1782_CR32","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/ni.3868","volume":"18","author":"T Maj","year":"2018","unstructured":"Maj T, Wang W, Crespo J, Zhang H, Wang W, Zhao L, et al. Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor. Nat Immunol. 2018;18:1332\u201341.","journal-title":"Nat Immunol"},{"key":"1782_CR33","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/SLA.0000000000002985","volume":"271","author":"K Okadome","year":"2020","unstructured":"Okadome K, Baba Y, Yagi T, Kiyozumi Y, Ishimoto T, Iwatsuki M, et al. Prognostic Nutritional Index, tumor-infiltrating lymphocytes, and prognosis in patients with esophageal cancer. Ann Surg. 2020;271:693\u2013700.","journal-title":"Ann Surg"},{"key":"1782_CR34","first-page":"1","volume":"17","author":"H Kitahara","year":"2021","unstructured":"Kitahara H, Shoji F, Akamine T, Kinoshita F, Haratake N, Takenaka T, et al. Preoperative prognostic nutritional index level is associated with tumour-infiltrating lymphocyte status in patients with surgically resected lung squamous cell carcinoma. Eur J Cardio-Thoracic Surg. 2021;17:1\u20132.","journal-title":"Eur J Cardio-Thoracic Surg"},{"key":"1782_CR35","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cmet.2017.06.016","volume":"26","author":"RJ Kishton","year":"2017","unstructured":"Kishton RJ, Sukumar M, Restifo NP. Metabolic regulation of T cell longevity and function in tumor immunotherapy. Cell Metab. 2017;26:94\u2013109.","journal-title":"Cell Metab"},{"key":"1782_CR36","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.3390\/cancers12061410","volume":"12","author":"EHK Mok","year":"2020","unstructured":"Mok EHK, Lee TKW. The pivotal role of the dysregulation of cholesterol homeostasis in cancer: implications for therapeutic targets. Cancers (Basel). 2020;12:1410.","journal-title":"Cancers (Basel)"},{"key":"1782_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2017.12.019","volume":"417","author":"L Dyck","year":"2018","unstructured":"Dyck L, Lynch L. Cancer, obesity and immunometabolism\u2014connecting the dots. Cancer Lett. 2018;417:11\u201320.","journal-title":"Cancer Lett"},{"key":"1782_CR38","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nri3793","volume":"15","author":"AR Tall","year":"2015","unstructured":"Tall AR, Yvan-Chrvet L. Cholesterol inflammation and innate immunity. Nat Rev Immunol. 2015;15:104\u201316.","journal-title":"Nat Rev Immunol"},{"key":"1782_CR39","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/ni.3466","volume":"17","author":"R Newton","year":"2016","unstructured":"Newton R, Priyadharshini B, Turka LA. Immunometabolism of regulatory T cells. Nat Immunol. 2016;17:618\u201325.","journal-title":"Nat Immunol"},{"key":"1782_CR40","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","volume":"373","author":"H Borghaei","year":"2015","unstructured":"Borghaei H, Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE, et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med. 2015;373:1627\u201339.","journal-title":"N Engl J Med"},{"key":"1782_CR41","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa1504627","volume":"373","author":"J Brahmer","year":"2015","unstructured":"Brahmer J, Reckamp KL, Baas P, Crin\u00f2 L, Eberhardt WEE, Poddubskaya E, et al. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N Engl J Med. 2015;373:123\u201335.","journal-title":"N Engl J Med"},{"key":"1782_CR42","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","volume":"378","author":"L Gandhi","year":"2018","unstructured":"Gandhi L, Rodr\u00edguez-Abreu D, Gadgeel S, Esteban E, Felip E, De Angelis F, et al. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer. N Engl J Med. 2018;378:2078\u201392.","journal-title":"N Engl J Med"},{"key":"1782_CR43","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1056\/NEJMoa1910231","volume":"381","author":"MD Hellmann","year":"2019","unstructured":"Hellmann MD, Paz-Ares L, Bernabe Caro R, Zurawski B, Kim S-W, Carcereny Costa E, et al. Nivolumab plus Ipilimumab in advanced non-small-cell lung cancer. N Engl J Med. 2019;381:2020\u201331.","journal-title":"N Engl J Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-021-01782-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-021-01782-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-021-01782-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T01:03:12Z","timestamp":1639184592000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-021-01782-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1782"],"URL":"https:\/\/doi.org\/10.1186\/s12890-021-01782-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-948188\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-948188\/v2","asserted-by":"object"}]},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"6 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Board of Hamamatsu University School of Medicine (No. 21-151). Patient consent was waved because this was a retrospective study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have no competing of interest in relation to this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"409"}}